PRISM MarketView
    Clever Leaves Gains Exclusive License to Cultivate High Performance Cannabis
    New York, February 15, 2024 - PRISM MarketView - PRISM MediaWire - As part of its partnership with award-winning Dutch seed bank, Paradise Seeds, global medicinal cannabis company, Clever Leaves Holdings (Nasdaq: CLVR), will develop and register high performance cannabis...

    15 February 2024

    read more...
    PRISM MarketView
    Atara Biotherapeutics Files IND to Advance Lupus Treatment
    New York, February 15, 2024 - PRISM MarketView - PRISM MediaWire - Atara Biotherapeutics (Nasdaq: ATRA) has submitted an Investigational New Drug (IND) application to the FDA for the use of ATA3219 as a monotherapy for the treatment of systemic lupus erythematosus(SLE) w...

    15 February 2024

    read more...
    PRISM MarketView
    Soluna Holdings Dives into AI Hosting with Strategic Co-location Partnership
    New York, February 14, 2024 - PRISM MarketView - PRISM MediaWire - Soluna Holdings, Inc. (NASDAQ: SLNH), a pioneer in developing green data centers, has ventured into the AI hosting market through a landmark co-location agreement with a GPU startup specializing in AI com...

    14 February 2024

    read more...
    PRISM MarketView
    Inspira Technologies’ Stock Jumps Following First U.S. Patent for Blood Oxygenation System
    New York, February 14, 2024 - PRISM MarketView  - PRISM MediaWire - Inspira Technologies (Nasdaq: IINN), a pioneering medical technology company aiming to advance beyond traditional mechanical ventilators, has been granted the first-ever U.S. Patent for an orbiting blood...

    14 February 2024

    read more...
    PRISM MarketView
    Biotricity Expecting Record Margins for Q3
    New York, February 14, 2024 - PRISM MarketView - PRISM MediaWire - Technology-as-a-Service company, Biotricity (Nasdaq: BTCY) expects to announce record margins and operational efficiency for the third quarter of fiscal year 2024. The company is expecting record gross ma...

    14 February 2024

    read more...
    News
    Clubhouse Media Group, Inc. Announces Miss Global Contestant, Patricia Rath, Joins HoneyDrip.com
    LOS ANGELES, February 14, 2024 - PRISM MediaWire - Clubhouse Media Group, Inc. (OTC: CMGR) ("Clubhouse Media Group"), a social media firm, today announced that fashion model and social media influencer, Patricia Rath, has joined HoneyDrip.com. Rath competed in both Miss ...

    14 February 2024

    read more...
    PRISM MarketView
    PRISM EV Index Update: Beam Global Expands Federal Presence
    New York, February 13, 2024 - PRISM MarketView -PRISM MediaWire -Beam Global (Nasdaq: BEEM), a sustainable infrastructure pioneer for transportation electrification and energy security, has made significant strides by securing first-time orders from six federal entities ...

    13 February 2024

    read more...
    PRISM MarketView
    PRISM Insight: Cannabis Stocks May Be Seeing Green During Marijuana Awareness Month as Investors Wait on DEA’s Rescheduling Decision
    New York, February 13, 2024 - PRISM MarketView - PRISM MediaWire - Cannabis stocks are seeing a resurgence as investors await a decision from the DEA on potentially rescheduling marijuana. The AdvisorShares Pure US Cannabis ETF and other related ETFs have shown significa...

    13 February 2024

    read more...
    PRISM MarketView
    Adverum Demonstrates “Sustained Disease Control” in Phase 2 Trial for Macular Degeneration
    New York, February 13, 2024 - PRISM MarketView - PRISM MediaWire - Adverum Biotechnologies (Nasdaq: ADVM) has reported positive preliminary safety and efficacy data from a Phase 2 trial in patients with wet age-related macular degeneration (AMD) at the 47th Annual Meetin...

    13 February 2024

    read more...
    PRISM MarketView
    FDA Fast Track for BioXcel’s Prostate Cancer Treatment
    New York, February 13, 2024 - PRISM MarketView - PRISM MediaWire -  Biopharmaceutical company, BioXcel Therapeutics, Inc. (Nasdaq: BTAI), has been granted FDA Fast Track designation for BXCL701 in combination with a CPI for the treatment of patients with metastatic small...

    13 February 2024

    read more...
    47
    48
    49
    50
    51
    52
    53
    We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
    Cookie settings
    Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
    Necessary cookies
    Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
    Preferences
    Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
    Analytical cookies
    Analytical cookies help us improve our website by collecting and reporting information on its usage.
    Marketing cookies
    Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.